
| luisa.sambati@ausl.bologna.it |
3207959682 |
| Bologna (Emilia-Romagna) Italy |
Medical Director
U.O.C. Clinica Neurologica Rete Metropolitana, Neurometeptember 15, 2008: Master's Degree in Medicine and Surgery from the University of Bologna - Alma Mater Studiorum, discussing a thesis on the progression “From subjective cognitive impairment to dementia†(Prof. R. Gallassi).
Since 2008, he has been collaborating with the Cognitive Disorders Center (Prof. R. Gallassi) and the Movement Disorders Center of the Neurological Clinic of Bologna (Prof. P. Cortelli). In 2014, he obtained his Doctorate in Specialized Medical Sciences with a thesis on cognitive and affective behavioral assessment in Parkinson's syndromes (Prof. P. Cortelli).
In 2017, he furthered his interest in cognitive disorders and dementia at the Institut de la mémoire et de la maladie d'Alzheimer. Département des maladies du système nerveux. Hôpital de la Pitié Salpêtrière, AP-HP (Prof. B. Dubois).
In 2018, he obtained his specialist qualification in Neurology with a thesis on the assessment of cognitive profiles in patients with Multisystem Atrophy. She worked as a Research Fellow at the NEUROMET Neurological Clinic (Prof. P. Cortelli) on the topic of speech and language disorders and the spectrum of Frontotemporal Lobar Degeneration, and obtained a Master's Degree in Clinical Neuropsychology at the University of Padua in 2019, discussing a thesis on the longitudinal clinical and neuropsychological assessment of patients with REM sleep behavior disorder.
Since March 1, 2021, she has been a Specialist Medical Director in Neurology at the U.O.C Clinica Neurologica Rete Metropolitana (NEUROMET), IRCCS Institute of Neurological Sciences in Bologna, where she carries out clinical and research activities at the Cognitive Disorders and Dementia Center and the Movement Disorders Center. His main areas of clinical interest concern patients with cognitive impairment and the assessment of patients with different forms of dementia and movement disorders, from the early to the most advanced stages of the disease.

